Bicara Therapeutics Inc.
BCAX
24 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 36,766 | $19.17 | $704.7K | 339,392(D) | View → |
| Mar 9, 2026 | Mar 9 8:06 PM | Mazumdar Claire | Proposed Sale | 36,766 | $19.17 | $704.7K | — | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 3,817 | $18.75 | $71.6K | 339,392(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 1,786 | $18.74 | $33.5K | 339,392(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 2,631 | $18.73 | $49.3K | 339,392(D) | View → |
| Mar 6, 2026 | Mar 6 9:01 PM | Mazumdar Claire | Proposed Sale | 3,817 | $19.80 | $75.6K | — | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Sale | 17,392 | $18.16 | $315.9K | 205,141(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Sale | 2,963 | $18.25 | $54.1K | 145,355(D) | View → |
| Mar 3, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Sale | 13,555 | $18.22 | $246.9K | 145,355(D) | View → |
| Mar 4, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Sale | 16,300 | $18.52 | $301.9K | 55,286(D) | View → |
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Sale | 200 | $18.45 | $3.7K | 55,286(D) | View → |
| Mar 5, 2026 | Mar 5 9:04 PM | Mazumdar Claire | Proposed Sale | 1,786 | $18.74 | $33.5K | — | View → |
| Mar 4, 2026 | Mar 4 9:32 PM | Hyep Ivan | Proposed Sale | 2,963 | $18.25 | $54.1K | — | View → |
| Mar 4, 2026 | Mar 4 9:31 PM | Mazumdar Claire | Proposed Sale | 2,631 | $18.73 | $49.3K | — | View → |
| Mar 4, 2026 | Mar 4 9:21 PM | Raben David | Proposed Sale | 16,300 | $18.52 | $301.9K | — | View → |
| Mar 3, 2026 | Mar 3 9:48 PM | Hyep Ivan | Proposed Sale | 13,555 | $18.22 | $246.9K | — | View → |
| Mar 3, 2026 | Mar 3 9:11 PM | Raben David | Proposed Sale | 200 | $18.45 | $3.7K | — | View → |
| Mar 3, 2026 | Mar 3 9:09 PM | Cohlhepp Ryan | Proposed Sale | 17,392 | $18.16 | $315.9K | — | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 300,000 | $16.00 | $4.8M | 4,603,418(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Sale | 3,631 | $18.04 | $65.5K | 209,641(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 12 8:04 PM | William SchelmanChief Medical Officer | Grant/Award | 85,000 | $22.58 | 85,000(D) | View → |
| Apr 27, 2026 | Apr 28 11:49 PM | David RabenChief Medical Officer | Option Exercise | 5,500 | $3.79 | 41,913(D) | View → |
| Apr 21, 2026 | Apr 22 8:53 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 39,744(D) | View → |
| Apr 20, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 15,000 | $3.79 | 161,107(D) | View → |
| Apr 16, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 22,760 | $5.45 | 558,432(D) | View → |
| Apr 15, 2026 | Apr 17 8:55 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 109,334(D) | View → |
| Mar 25, 2026 | Mar 26 11:21 PM | David RabenChief Medical Officer | Option Exercise | 5,500 | $3.79 | 47,413(D) | View → |
| Mar 23, 2026 | Mar 24 11:45 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 48,944(D) | View → |
| Mar 20, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,596 | $3.79 | 176,107(D) | View → |
| Mar 19, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 6,905 | $3.79 | 177,703(D) | View → |
| Mar 18, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 6,499 | $3.79 | 184,608(D) | View → |
| Mar 16, 2026 | Mar 17 9:36 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 117,334(D) | View → |
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 36,766 | $3.79 | 191,107(D) | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 3,817 | $3.79 | 227,873(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,786 | $3.79 | 231,690(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 2,631 | $3.79 | 233,476(D) | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Option Exercise | 12,892 | $3.79 | 125,334(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 2,963 | $3.79 | 79,784(D) | View → |
| Mar 3, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 13,555 | $3.79 | 82,747(D) | View → |
| Mar 4, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 16,300 | $3.79 | 52,913(D) | View → |
Page 1 of 2
Next →